ICP ADVISORS

82% of executives think they know who they're selling to. The data says they're wrong.

We run a four-week diagnostic that gives B2B SaaS leadership one evidence-backed answer to the question that decides everything else in revenue: who should you actually be selling to?

WHAT YOU GET

Our ICP Growth Diagnostic delivers higher win rates, better retention, and sales capacity that compounds.

A four-week, evidence-backed engagement that translates ICP clarity into measurable pipeline movement across sales, marketing, and customer success. Three things change immediately — and compound from there.

Win rates climb. Cycle times drop.

When sales is working on ICP-fit deals, win rates rise and cycles shorten — often meaningfully within a quarter. The pipeline gets smaller, the close rate gets sharper, and the forecast gets honest.

NRR moves up. Early churn falls.

ICP-fit customers expand at multiples of out-of-ICP customers, and churn at fractions of the rate. Net revenue retention isn't a CS problem — it's a targeting problem that shows up in CS.

Sales capacity goes to deals that close.

Reps know who to chase and who to disqualify. Marketing spend lands where your ICP actually buys. New AEs ramp faster against a sharp profile. The same team produces measurably more revenue.

THE PROBLEM

Companies with a clearly defined ICP see 68% higher win rates. Below-benchmark win rate is almost never a sales execution problem.

SOURCE: SiriusDecisions (now Forrester) B2B Revenue Research

The research is unambiguous — and it points to a different root cause than most leadership teams are addressing. Three things B2B SaaS teams routinely believe, and what the data actually shows.

"We know our ICP."

You have a slide. The customers who actually close, expand, and renew often don't match it. Most ICPs were defined early, never re-validated against closed-won data, and have quietly drifted out of date.

"Win rate is a sales execution problem."

82% of executives believe their sales and marketing teams are aligned on who they're selling to. 65% of the people doing the work disagree. The gap between those two numbers is where pipeline gets misallocated quarter after quarter.Forrester, 2024

"Sales and marketing agree on who we sell to."

Only 8% of B2B companies achieve genuine sales-marketing alignment. Ask the two teams separately — the answers rarely match. The cost shows up in lead rejection rates, blame loops, and stalled pipeline.Forrester, 2024

WHEN TO WORK WITH US

Three signals it's time for the diagnostic.

Different starting points, same engagement. The four-week ICP Growth Diagnostic is built to meet leadership teams wherever they are on the curve.

4
Weeks from kickoff to executive readout. Not four quarters.
100%
Engagements led by senior operators. No analysts learning on your dime.
1
ICP your whole company commits to. Sales, marketing, product, CS.
WHO WE WORK WITH

Built for one kind of leadership team.

If the description below isn't yours, we're probably not the right fit — and we'd rather know that on the first call than the fourth.

The Profile
  • Category B2B SaaS, post product-market fit
  • Stage $5M–$50M ARR
  • Pattern Growing — but unevenly
  • Signal Leadership can feel something is off in pipeline before it shows up in the numbers
Built For
  • CROs holding revenue targets that aren't compounding
  • VPs of Sales watching win rates quietly slide
  • CEOs preparing for a raise, a board, or an exit
  • Leadership teams who want one honest answer — not a six-month consulting engagement
One ICP. Four weeks. Senior-led from kickoff to executive readout.
SELECTED ENGAGEMENTS

Recent work.

Anonymized at client request. Outcomes are the actual numbers.

LET'S TALK

Book a 30-minute call. We'll know fast if we're the right fit.

A direct conversation about your pipeline reality and what's getting in the way. If the diagnostic is what you need next, we'll tell you. If it isn't, we'll tell you that too.

Book a 30-minute call